Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
8.87
-0.63 (-6.63%)
At close: Mar 12, 2026, 4:00 PM EDT
8.90
+0.03 (0.34%)
After-hours: Mar 12, 2026, 7:40 PM EDT

Ocular Therapeutix Revenue

In the year 2025, Ocular Therapeutix had annual revenue of $51.95M, down -18.47%. Ocular Therapeutix had revenue of $13.25M in the quarter ending December 31, 2025, a decrease of -22.43%.

Revenue (ttm)
$51.95M
Revenue Growth
-18.47%
P/S Ratio
37.17
Revenue / Employee
$159,849
Employees
325
Market Cap
1.93B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202551.95M-11.77M-18.47%
Dec 31, 202463.72M5.28M9.03%
Dec 31, 202358.44M6.95M13.49%
Dec 31, 202251.49M7.97M18.32%
Dec 31, 202143.52M26.12M150.08%
Dec 31, 202017.40M13.18M311.71%
Dec 31, 20194.23M2.24M112.41%
Dec 31, 20181.99M67.00K3.48%
Dec 31, 20171.92M36.00K1.91%
Dec 31, 20161.89M137.00K7.83%
Dec 31, 20151.75M978.00K126.68%
Dec 31, 2014772.00K--
Dec 31, 2013---
Dec 31, 201210.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition